In addition, CRP not only serves as a biomarker for AS but also contributes to thrombosis risk by impairing endothelial function, promoting endothelial dysfunction, and inducing the release of circulating endothelial cells and endothelial microparticles [32,33]. The gene discussed is CRP; the disease is endothelial dysfunction.